(A) Mean (s.d.) ... (A) Mean (s.d.) baseline values for study variables for patients with and without tophi. (B) Baseline (s.d.) quality of life scores.

Slides:

Advertisements

Similar presentations

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Advertisements

Fig. 1 Flow chart of the literature search

Figure 1 Data-selection process

Figure 1 Flow diagram detailing the systematic review process.

Figure 1 Multivariable-adjusted predictors of PAC

(A) Calcinosis cutis on the extensor side of the left upper arm ...

Figure 1 Mechanism of mortality benefit associated with radial access

(A) mSchober in DESIR; (B) mSchober in SPACE; (C) LSF ...

Figure 1 Phases of the research. Author’s own work.

(A–B) Images of US ... (A–B) Images of US assessment of both patients who developed peripheral arthritis during vedolizumab treatment undergoing US-guided.

Fig. 1 Bone scintigraphy of the right tibia of the patient at disease onset (A), after 10 years of calcitonin ... Fig. 1 Bone scintigraphy of the right.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.

AHA: American Heart Association; ALT: ...

Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.

Figure 1 A dot plot illustrating the correlation between the yearly absolute risk difference for both MACE and major ... Figure 1 A dot plot illustrating.

Fig. 1 CT demonstrating aortic wall thickening with renal artery involvement (short arrow). There is also subtle ... Fig. 1 CT demonstrating aortic wall.

(A) Axial ... (A) Axial images showed symmetric, strong high intensity in the connective tissues surrounded by femoral muscles and mild high intensity.

bDMARD: biologic DMARD.

(A) Upper ... (A) Upper gastroduodenoscopy showing gastric antral vascular ectasia with visible bleeding. (B) Nailfold capillaroscopy showing dilated capillaries.

(A) Pelvic X-ray showing diffuse osteoaddensing ...

Black: diagnosis ... Black: diagnosis from any department; grey: diagnosis at a rheumatology department. Unless provided in the caption above, the following.

RCTs: randomized controlled ...

(A, B) Upon presentation large, scaly, annular plaques with well-defined, erythematous, raised ... (A, B) Upon presentation large, scaly, annular plaques.

Point estimates with ... Point estimates with 95% CI. HR: hip replacement; KR: knee replacement. Unless provided in the caption above, the following copyright.

Fig. 1 Graphical representation of improving mortality in stroke patients since the inception of a national stroke ... “Graph courtesy of George Dunn,

Fig. 1 MRI aspect of an osteitis of the left acetabulum at baseline (A), 3 months (B), 1 year (C) and 2 years later, ... Fig. 1 MRI aspect of an osteitis.

High IFN-α levels were found in patient’s serum, and ...

Figure 1. Historical dialectic framework to assess transnational advocacy network influence Unless provided in the caption above, the following copyright.

Take home figure The protective role of CNP/NPR-B/NPRC.

Fig. 3 Interrelationship between themes describing the experiences of people with shoulder disorders Unless provided in the caption above, the following.

A. PMPs; B. endotheliocyte-derived MPs; C. leukocyte-derived MPs

x-axis, post-partum days. Closed ...

Fig. 1 HRCT of the chest, showing centrilobular nodules (white arrows in A and B), a large subpleural nodule (black ... Fig. 1 HRCT of the chest, showing.

Fig. 1. A flowchart of cohort participants screened, enrolled and followed-up between 1 July 2015 and 31 May Fig. 1. A flowchart of cohort participants.

Fig. 1 Papules in an old tattoo as the presenting sign of systemic sarcoidosis in an otherwise asymptomatic ... (A) Nodular papules in the tattoo. (B)

Fig. 1 Subacute cutaneous lupus erythematous at the lower limbs

Fig. 1 Flow chart of included patients for analyses

Rats were treated for 21 days ...

Fig. 1 Flow chart for selection of study subjects

Figure 1 Plot showing the interaction between Indigenous group belonging and use of family health centres Figure 1 Plot showing the interaction between.

Prevalence and distribution of ...

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Figure 1 Relationships between pair indices of dance performance (joint entropy or mutual information) and the past ... Figure 1 Relationships between.

Figure 1. Flow diagram for selection of articles for systematic review. Unless provided in the caption above, the following copyright applies to the content.

Figure 1. Time–kill studies for selected isolates (each line represents the average of duplicate studies). AMP, ... Figure 1. Time–kill studies for selected.

Figure 1. Percentage of Pacific and European children completing all components of B4SC in 2013 and 2015 Figure 1. Percentage of Pacific and European.

Psoriatic target lesion at (A) ...

(A) Hypoechoic ‘halo sign’ of ...

Figure 1. Trunk and leg fat over study period. LS, log transformed.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Fig. 1 Kaplan-Meier plot presenting no difference in progression to RA in patients with clinically suspect ... Fig. 1 Kaplan-Meier plot presenting no difference.

Figure 1. Oncoprint of selected pathogenic alterations detected in ctDNA. Unless provided in the caption above, the following copyright applies to the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

The independent additive value of total greyscale + power Doppler synovitis ... The independent additive value of total greyscale + power Doppler synovitis.

Fig. 1 A network representation of top 100 co-occurring terms

Fig. 1 Statistics of the main characters’ dialogues.

Figure 1 Patient selection.

Fig. 1 Query formulation process in CLIR

The figure shows the fraction of ...

Figure 1 Grant agencies and charitable foundations supporting Plan S.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Fig. 1 Schematic subcategorization of AAV in three clinically relevant disease categories defined by clinical ... Fig. 1 Schematic subcategorization of.

Figure 1 Strategies for reconciling protection and participation.

(A, B) Upon presentation large, scaly, annular plaques with well-defined, erythematous, raised ... (A, B) Upon presentation large, scaly, annular plaques.

Figure 1 ABCDE of primary prevention.2

Figure 1. Forest plot of lung cancer mortality in LDCT trials.

Table 2. Mean noise level results for hand dryers in dBA

Presentation transcript:

(A) Mean (s.d.) ... (A) Mean (s.d.) baseline values for study variables for patients with and without tophi. (B) Baseline (s.d.) quality of life scores (SF-36) for patients with and without tophi. SF-36: Medical Outcomes Study Short Form 36. PGA: Patient Global Assessment. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.comThis article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) Rheumatology (Oxford), kez017, https://doi.org/10.1093/rheumatology/kez017 The content of this slide may be subject to copyright: please see the slide notes for details.

P < 0.0001 for stage 1 vs stage 2; P ... P < 0.0001 for stage 1 vs stage 2; P < 0.0001 for stage 1 vs stage 3; P = 0.047 for stage 1 vs stage 4, P < 0.0001 for stage 2 vs stage 4. eGFR: estimated glomerular filtration rate. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.comThis article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) Rheumatology (Oxford), kez017, https://doi.org/10.1093/rheumatology/kez017 The content of this slide may be subject to copyright: please see the slide notes for details.

Data are reported as mean (s.d.). ... Data are reported as mean (s.d.). HAQ-DI: Health Assessment Questionnaire-Disability Index; SF-36: Medical Outcomes Study Short Form 36; VAS: visual analogue scale. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.comThis article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) Rheumatology (Oxford), kez017, https://doi.org/10.1093/rheumatology/kez017 The content of this slide may be subject to copyright: please see the slide notes for details.

Data are reported as mean (s.d.). SF-36: Medical ... Data are reported as mean (s.d.). SF-36: Medical Outcomes Study Short Form 36; RCT: randomized controlled trial. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.comThis article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) Rheumatology (Oxford), kez017, https://doi.org/10.1093/rheumatology/kez017 The content of this slide may be subject to copyright: please see the slide notes for details.

Data are reported as mean (s.d.). ... Data are reported as mean (s.d.). eGFR: estimated glomerular filtration rate; OLE: open-label extension. Unless provided in the caption above, the following copyright applies to the content of this slide: © The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.comThis article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) Rheumatology (Oxford), kez017, https://doi.org/10.1093/rheumatology/kez017 The content of this slide may be subject to copyright: please see the slide notes for details.